whi p154 has been researched along with Adenocarcinoma in 2 studies
WHI P154: an anti-leukemic agent; structure in first source
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, YW | 1 |
| Tu, PH | 1 |
| Lin, KT | 1 |
| Lin, SC | 1 |
| Ko, JY | 1 |
| Jou, YS | 1 |
| Sudbeck, EA | 1 |
| Ghosh, S | 1 |
| Liu, XP | 1 |
| Zheng, Y | 1 |
| Myers, DE | 1 |
| Uckun, FM | 1 |
1 review available for whi p154 and Adenocarcinoma
| Article | Year |
|---|---|
Tyrosine kinase inhibitors against EGF receptor-positive malignancies.
Topics: Adenocarcinoma; Amides; Aniline Compounds; Animals; Antineoplastic Agents; Breast Neoplasms; Drug De | 2001 |
1 other study available for whi p154 and Adenocarcinoma
| Article | Year |
|---|---|
Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Anaplastic Lymphoma Kinase; Animals; Biomarkers | 2011 |